Argos Therapeutics CEO Jeffrey Abbey on U.S. Biotech-Japan Pharma Collaborations: An Interview With PharmAsia News (Part 1 Of 2)
This article was originally published in PharmAsia News
Executive Summary
North Carolina-based Argos Therapeutics CEO Jeffrey Abbey recently spoke with PharmAsia News about the unique opportunities and challenges for U.S. biotechs looking to collaborate with Japanese pharma companies. Abbey discussed his experience partnering with Kirin Pharma and why it is a good time for U.S. biotechs to look for Japanese partners.